Original Research

BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo

Zhou Q

OncoTargets and Therapy 2015, 8:689-697

Published Date: 2 April 2015